Rachel Mcminn's Net Worth
Rachel Mcminn's net worth is estimated to be at least $1,258,296.38 as of 12/26/2024. CoreStreet's estimation of Rachel Mcminn's net worth is based on their sale of stock and current holding of stock.
Rachel Mcminn is CEO at Neurogene Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 47,500 units of NGNE stock on 11/22/2024. Their biggest sale was on 01/03/2017 when they sold 816 units of Intercept Pharmaceuticals Inc stock for $84,798.72. They typically trade 2 times per year.
Total value of insider buys:
- $969,000.00
Total value of insider sells:
- $289,296.38
Most recent insider trade:
- Nov. 22, 2024
Rachel Mcminn's Insider Trading History
| Neurogene Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 22, 2024 | CEO | 47,500 | $20.40 | Buy | $969,000.00 |
| Intercept Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Oct. 2, 2017 | Insider | 283 | $58.89 | Sell | $16,665.87 |
July 31, 2017 | Insider | 130 | $123.12 | Sell | $16,005.60 |
May 1, 2017 | Insider | 114 | $113.12 | Sell | $12,895.68 |
Jan. 3, 2017 | Insider | 816 | $103.92 | Sell | $84,798.72 |
Oct. 31, 2016 | Insider | 129 | $123.82 | Sell | $15,972.78 |
Aug. 1, 2016 | Insider | 125 | $176.57 | Sell | $22,071.25 |
May 2, 2016 | Insider | 130 | $147.49 | Sell | $19,173.70 |
Feb. 1, 2016 | Insider | 128 | $103.56 | Sell | $13,255.68 |
Jan. 4, 2016 | Insider | 469 | $145.90 | Sell | $68,427.10 |
Nov. 2, 2015 | Insider | 125 | $160.24 | Sell | $20,030.00 |